The World Health Organization confirmed that it needs more information to assess the effectiveness of the vaccine against the Corona virus, which is developed by the British-Swedish "AstraZeneca" company in cooperation with the University of Oxford.

Catherine O'Brien, Director of the Department of Immunization, Vaccines and Biology at the World Organization, said during a conference held on Friday, in response to a question about the organization’s evaluation of the AstraZeneca vaccine: “What we have seen is a press release, and the next step is very important will be to evaluate the information based on more From a press release. "

O'Brien stressed that the United Nations organization is looking forward to obtaining more data on the vaccine and gaining an opportunity to ask questions about it, saying: "I think it is too early to talk about how we deal with the data and what we need next."

For her part, the chief scientist at the World Health Organization, Sumiya Swaminathan, confirmed that all the information available to the organization so far about this vaccine comes from the aforementioned press release, indicating the need for more tests, especially with the aim of verifying the validity of the recent conclusions. The effectiveness of the vaccine among volunteers who received two full doses of it reached 62%, compared to 90% among volunteers who received half a dose and then a full dose.

Source: Axios + Sky News

By:Nadeemy Haded